{"id":"https://openalex.org/W7129093003","doi":"https://doi.org/10.1093/ofid/ofag069","title":"Population Pharmacokinetic Modeling and Target Attainment of Cefepime in Critically Ill Pediatric Patients","display_name":"Population Pharmacokinetic Modeling and Target Attainment of Cefepime in Critically Ill Pediatric Patients","publication_year":2026,"publication_date":"2026-02-01","ids":{"openalex":"https://openalex.org/W7129093003","doi":"https://doi.org/10.1093/ofid/ofag069","pmid":"https://pubmed.ncbi.nlm.nih.gov/41767633"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofag069","doi":"https://doi.org/10.1093/ofid/ofag069","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofag069","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ofid/ofag069","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058052139","display_name":"Stephanie L. Rolsma","orcid":"https://orcid.org/0000-0002-7636-2222","observed_orcids":["https://orcid.org/0000-0002-7636-2222"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie L Rolsma","raw_affiliation_strings":["Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center , Nashville, Tennessee ,","Vanderbilt University School of Medicine , Nashville, Tennessee ,","Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center , Nashville, Tennessee ,"],"raw_orcid":"https://orcid.org/0000-0002-7636-2222","affiliations":[{"raw_affiliation_string":"Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center , Nashville, Tennessee ,","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Vanderbilt University School of Medicine , Nashville, Tennessee ,","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center , Nashville, Tennessee ,","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011708827","display_name":"Marisa H. Blackman","orcid":"https://orcid.org/0000-0002-9898-185X","observed_orcids":["https://orcid.org/0000-0002-9898-185X"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marisa Blackman","raw_affiliation_strings":["Department of Biostatistics, Vanderbilt University Medical Center , Nashville, Tennessee ,"],"raw_orcid":"https://orcid.org/0000-0002-9898-185X","affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Vanderbilt University Medical Center , Nashville, Tennessee ,","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016858483","display_name":"Cole Beck","orcid":"https://orcid.org/0000-0002-6849-6255","observed_orcids":["https://orcid.org/0000-0002-6849-6255"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cole Beck","raw_affiliation_strings":["Department of Biostatistics, Vanderbilt University Medical Center , Nashville, Tennessee ,"],"raw_orcid":"https://orcid.org/0000-0002-6849-6255","affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Vanderbilt University Medical Center , Nashville, Tennessee ,","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083600113","display_name":"Ahmad Dbouk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmad Dbouk","raw_affiliation_strings":["Department of Medicine, Vanderbilt University Medical Center , Nashville, Tennessee ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Vanderbilt University Medical Center , Nashville, Tennessee ,","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021228088","display_name":"Foday Morovia","orcid":"https://orcid.org/0000-0002-4013-2572","observed_orcids":["https://orcid.org/0000-0002-4013-2572"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Foday Morovia","raw_affiliation_strings":["Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center , Nashville, Tennessee ,"],"raw_orcid":"https://orcid.org/0000-0002-4013-2572","affiliations":[{"raw_affiliation_string":"Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center , Nashville, Tennessee ,","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069335375","display_name":"Faith Glover","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Faith Glover","raw_affiliation_strings":["Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center , Nashville, Tennessee ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center , Nashville, Tennessee ,","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115847762","display_name":"Gabriella Ess","orcid":"https://orcid.org/0009-0008-1329-7460","observed_orcids":["https://orcid.org/0009-0008-1329-7460"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriella Ess","raw_affiliation_strings":["Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center , Nashville, Tennessee ,"],"raw_orcid":"https://orcid.org/0009-0008-1329-7460","affiliations":[{"raw_affiliation_string":"Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center , Nashville, Tennessee ,","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113589918","display_name":"Katelyn Dohler","orcid":"https://orcid.org/0009-0003-2639-1396","observed_orcids":["https://orcid.org/0009-0003-2639-1396"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katelyn Dohler","raw_affiliation_strings":["Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center , Nashville, Tennessee ,"],"raw_orcid":"https://orcid.org/0009-0003-2639-1396","affiliations":[{"raw_affiliation_string":"Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center , Nashville, Tennessee ,","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056293140","display_name":"Brian C. Bridges","orcid":"https://orcid.org/0000-0003-2209-2121","observed_orcids":["https://orcid.org/0000-0003-2209-2121"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Bridges","raw_affiliation_strings":["Division of Pediatric Critical Care, Department of Pediatrics, Medical University of South Carolina , Charleston, South Carolina ,"],"raw_orcid":"https://orcid.org/0000-0003-2209-2121","affiliations":[{"raw_affiliation_string":"Division of Pediatric Critical Care, Department of Pediatrics, Medical University of South Carolina , Charleston, South Carolina ,","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055852387","display_name":"Leena Choi","orcid":"https://orcid.org/0000-0002-2544-7090","observed_orcids":["https://orcid.org/0000-0002-2544-7090"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leena Choi","raw_affiliation_strings":["Department of Biostatistics, Vanderbilt University Medical Center , Nashville, Tennessee ,"],"raw_orcid":"https://orcid.org/0000-0002-2544-7090","affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Vanderbilt University Medical Center , Nashville, Tennessee ,","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067425596","display_name":"Clarence Buddy Creech","orcid":"https://orcid.org/0000-0002-8276-9053","observed_orcids":["https://orcid.org/0000-0002-8276-9053"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C Buddy Creech","raw_affiliation_strings":["Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center , Nashville, Tennessee ,","Vanderbilt University School of Medicine , Nashville, Tennessee ,","Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center , Nashville, Tennessee ,"],"raw_orcid":"https://orcid.org/0000-0002-8276-9053","affiliations":[{"raw_affiliation_string":"Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center , Nashville, Tennessee ,","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Vanderbilt University School of Medicine , Nashville, Tennessee ,","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center , Nashville, Tennessee ,","institution_ids":["https://openalex.org/I901861585"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":4.0337,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.89156312,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"13","issue":"2","first_page":"ofag069","last_page":"ofag069"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cefepime","display_name":"cefepime","score":1.0},{"id":"https://openalex.org/keywords/population-pharmacokinetic-model","display_name":"population pharmacokinetic model","score":0.8799999952316284},{"id":"https://openalex.org/keywords/critically-ill-children","display_name":"critically ill children","score":0.8050000071525574},{"id":"https://openalex.org/keywords/pediatric-intensive-care","display_name":"pediatric intensive care","score":0.6050000190734863},{"id":"https://openalex.org/keywords/probability-of-target-attainment","display_name":"probability of target attainment","score":0.9359999895095825},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.7519999742507935},{"id":"https://openalex.org/keywords/prolonged-infusion","display_name":"prolonged infusion","score":0.6669999957084656},{"id":"https://openalex.org/keywords/continuous-infusion","display_name":"continuous infusion","score":0.8640000224113464},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.7630000114440918},{"id":"https://openalex.org/keywords/weight-based-dosing","display_name":"weight-based dosing","score":0.7680000066757202},{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa","display_name":"Pseudomonas aeruginosa","score":0.847000002861023},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.9139999747276306},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.9649999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9523000121116638},{"id":"https://openalex.org/C2991859549","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Critically ill","level":2,"score":0.8353000283241272},{"id":"https://openalex.org/C2777050379","wikidata":"https://www.wikidata.org/wiki/Q2552927","display_name":"Cefepime","level":5,"score":0.7699000239372253},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7512999773025513},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.7283999919891357},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.544700026512146},{"id":"https://openalex.org/C2993568657","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Critical illness","level":3,"score":0.4797999858856201},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.43959999084472656},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4049000144004822},{"id":"https://openalex.org/C3020755252","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Population pharmacokinetics","level":3,"score":0.3840999901294708},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.36309999227523804},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.310699999332428},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3066999912261963},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.26980000734329224},{"id":"https://openalex.org/C2987404301","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care","level":2,"score":0.26669999957084656}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/ofid/ofag069","doi":"https://doi.org/10.1093/ofid/ofag069","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofag069","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:41767633","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41767633","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open forum infectious diseases","raw_type":"Clinical Trial"},{"id":"pmh:oai:pubmedcentral.nih.gov:12947848","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12947848/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofag069","doi":"https://doi.org/10.1093/ofid/ofag069","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofag069","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1982910325","https://openalex.org/W2018345158","https://openalex.org/W2020284110","https://openalex.org/W2064358970","https://openalex.org/W2070242840","https://openalex.org/W2073122282","https://openalex.org/W2102663241","https://openalex.org/W2108794518","https://openalex.org/W2511809475","https://openalex.org/W2614667954","https://openalex.org/W2741916112","https://openalex.org/W2767433671","https://openalex.org/W2769596897","https://openalex.org/W2885532202","https://openalex.org/W2899059770","https://openalex.org/W2901555047","https://openalex.org/W2911634754","https://openalex.org/W2964339291","https://openalex.org/W2969873003","https://openalex.org/W2991594499","https://openalex.org/W3037692841","https://openalex.org/W3123685372","https://openalex.org/W3129921430","https://openalex.org/W3186629879","https://openalex.org/W3203882502","https://openalex.org/W4200292858","https://openalex.org/W4220748787","https://openalex.org/W4220916546","https://openalex.org/W4282919674","https://openalex.org/W4384660897","https://openalex.org/W4386116578","https://openalex.org/W4403187518"],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Cefepime":[2,33,58],"dosing":[3,34,142,207,221],"guidelines":[4],"are":[5],"well":[6],"defined":[7],"in":[8,17,26,164,190,208,243],"healthy":[9],"populations":[10],"but":[11],"have":[12,23],"not":[13],"been":[14],"studied":[15],"extensively":[16],"critically":[18,45,191,246],"ill":[19,46,192,247],"children":[20,47],"who":[21],"often":[22],"significant":[24],"alterations":[25],"antibiotic":[27],"pharmacokinetics":[28],"(PK)":[29],"and":[30,114,201,216,232],"pharmacodynamics":[31],"(PD).":[32],"optimization":[35],"is":[36,222],"important":[37],"for":[38,134,140,154,224,229],"patient":[39],"outcomes.":[40],"Method":[41],"We":[42],"prospectively":[43],"enrolled":[44],"receiving":[48],"cefepime.":[49],"Plasma":[50],"samples":[51],"were":[52,61,97],"collected":[53],"at":[54,170,175],"opportunistic":[55],"time":[56],"points.":[57],"plasma":[59],"concentrations":[60],"measured":[62],"by":[63],"liquid-chromatography-tandem":[64],"mass":[65],"spectrometry.":[66],"Population":[67],"PK":[68],"(popPK)":[69],"analysis":[70],"was":[71,82,105],"conducted":[72],"with":[73,101,127,137,160],"a":[74],"priori":[75],"selected":[76,106],"covariates.":[77],"The":[78,211],"final":[79],"covariate":[80],"model":[81,104,119],"used":[83],"to":[84,166,182,204],"perform":[85],"probability":[86],"of":[87,112,213,236],"target":[88,130,226],"attainment":[89],"(PTA)":[90],"analysis.":[91],"Results":[92],"Data":[93],"from":[94],"84":[95],"participants":[96],"analyzed.":[98],"A":[99],"2-compartment":[100],"proportional":[102],"error":[103],"as":[107],"the":[108,155,171,176,187,244],"base":[109],"model.":[110],"Inclusion":[111],"weight":[113],"creatinine":[115],"clearance":[116],"(CrCl)":[117],"improved":[118],"fit.":[120],"Estimated":[121],"breakpoints\u2014the":[122],"highest":[123],"minimum":[124],"inhibitory":[125],"concentration":[126],"\u226590%":[128],"pharmacokinetic":[129],"attainment\u2014were":[131],"2-fold":[132,151],"higher":[133,152,168,177],"3-hour":[135,147,161],"compared":[136,159],"30-minute":[138],"infusions":[139,148,162,215],"q8h":[141],"regimens.":[143],"For":[144],"q12h":[145],"regimens,":[146],"also":[149],"yielded":[150],"breakpoints":[153,169],"lowest":[156],"target.":[157],"Continuous":[158],"resulted":[163],"4-":[165],"16-fold":[167],"same":[172],"daily":[173],"dose":[174],"targets.":[178],"Increased":[179],"CrCl":[180],"led":[181],"reduced":[183],"PTA.":[184],"Conclusions":[185],"Given":[186],"variability":[188],"observed":[189],"children,":[193],"clinicians":[194],"should":[195,239],"consider":[196],"incorporating":[197],"therapeutic":[198],"drug":[199],"monitoring":[200],"popPK":[202],"models":[203],"determine":[205],"optimal":[206],"this":[209],"population.":[210,248],"use":[212],"extended":[214],"more":[217],"frequent":[218],"or":[219],"continuous":[220],"beneficial":[223],"PK/PD":[225],"achievement,":[227],"particularly":[228],"Pseudomonas":[230],"aeruginosa":[231],"antimicrobial-resistant":[233],"pathogens.":[234],"Use":[235],"these":[237],"strategies":[238],"be":[240],"strongly":[241],"considered":[242],"pediatric":[245]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2026-02-17T00:00:00"}